To pay 600 mln usd up front (Il Sole 24 Ore Radiocor) - New York, 20 Aug - The US pharmaceutical group Johnson & Johnson said that it has entered into a definitive agreement to acquire V-Wave, a privately-held company focused on developing treatment options for patients with heart failure.

Under the terms of the agreement, J&J will acquire V-Wave for an upfront payment of 600 million dollars, with the potential for additional regulatory and commercial milestone payments up to approximately 1.1 billion dollars.

"The planned acquisition of V-Wave will extend Johnson & Johnson MedTech's position as an innovation leader in addressing cardiovascular disease. It will further accelerate its shift into high-growth and high-opportunity markets and will deepen its relationships with structural interventional cardiologists and heart failure specialists," the company said.

The transaction is expected to close before the end of 2024, it added.

J&J expects the transaction to dilute adjusted earnings per share by approximately 0.24 dollars in 2024 and about 0.06 dollars in 2025.

V-Wave will join Johnson & Johnson as part of Johnson & Johnson MedTech.

AAA-Web

(RADIOCOR) 20-08-24 19:18:05 (0480) 5 NNNN